TSPO and Alzheimer disease: In patients with AD, increased expression of the translocator protein (TSPO; the former peripheral benzodiazepine receptor or PBR) shows another possibility for neuroprotection that could be executed via TSPO-mediated stimulation of steroid synthesis; as such, its neuroprotective and neuroregenerative properties resulted in the inhibition of apoptotic cell death.